SAPHO syndrome successful treated with tildrakizumab.
G Licata, A Gambardella, G Calabrese… - Dermatologic …, 2021 - search.ebscohost.com
Dermatologic Therapy, 2021•search.ebscohost.com
Based on this evidence we decided to use tildrakizumab, an interleukin-23 inhibitor, to treat
a patient with therapy-refractory SAPHO syndrome which resulted in a significant
improvement of her condition. To our knowledge, this is the first case report of successful
treatment of SAPHO syndrome with tildrakizumab, proving that the IL-23 inhibitor
tildrakizumab is effective in the treatment of therapy-refractory SAPHO syndrome.[Extracted
from the article] Copyright of Dermatologic Therapy is the property of Hindawi Limited and its …
a patient with therapy-refractory SAPHO syndrome which resulted in a significant
improvement of her condition. To our knowledge, this is the first case report of successful
treatment of SAPHO syndrome with tildrakizumab, proving that the IL-23 inhibitor
tildrakizumab is effective in the treatment of therapy-refractory SAPHO syndrome.[Extracted
from the article] Copyright of Dermatologic Therapy is the property of Hindawi Limited and its …
Abstract
Based on this evidence we decided to use tildrakizumab, an interleukin-23 inhibitor, to treat a patient with therapy-refractory SAPHO syndrome which resulted in a significant improvement of her condition. To our knowledge, this is the first case report of successful treatment of SAPHO syndrome with tildrakizumab, proving that the IL-23 inhibitor tildrakizumab is effective in the treatment of therapy-refractory SAPHO syndrome.[Extracted from the article]
Copyright of Dermatologic Therapy is the property of Hindawi Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. Copyright applies to all Abstracts.
search.ebscohost.com
以上显示的是最相近的搜索结果。 查看全部搜索结果